Efrén Riu

Universitat Autònoma de Barcelona — Spain

Medicine · Health Sciences

19h-index1.9kcitations24works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic function and diabetes(15), Metabolism, Diabetes, and Cancer(9), Adipose Tissue and Metabolism(7), Virus-based gene therapy research(5), Diabetes Management and Research(4)

Publications24 total

The E1a Adenoviral Gene Upregulates the Yamanaka Factors to Induce Partial Cellular Reprogramming
Cells·2023· 3 citedOpen Access
Gene expression profiling in hearts of diabetic mice uncovers a potential role of estrogen-related receptor γ in diabetic cardiomyopathy
Molecular and Cellular Endocrinology·2016· 15 cited
HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance
Scientific Reports·2015· 32 citedOpen Access
Adipose Tissue Overexpression of Vascular Endothelial Growth Factor Protects Against Diet-Induced Obesity and Insulin Resistance
Diabetes·2012· 312 citedOpen Access
Phosphofructo-1-Kinase Deficiency Leads to a Severe Cardiac and Hematological Disorder in Addition to Skeletal Muscle Glycogenosis
PLoS Genetics·2009· 62 citedOpen Access
Silencing of Episomal Transgene Expression in Liver by Plasmid Bacterial Backbone DNA Is Independent of CpG Methylation
Molecular Therapy·2008· 160 citedOpen Access
Histone Modifications are Associated with the Persistence or Silencing of Vector-mediated Transgene Expression In Vivo
Molecular Therapy·2007· 146 citedOpen Access
Reversal of Type 1 Diabetes by Engineering a Glucose Sensor in Skeletal Muscle
Diabetes·2006· 60 citedOpen Access
539. Unraveling the Mechanisms Underlying Silencing/Activation of Episomal Vectors In Vivo
Molecular Therapy·2006Open Access
Increased Maintenance and Persistence of Transgenes by Excision of Expression Cassettes from Plasmid Sequences <i>In Vivo</i>
Human Gene Therapy·2005· 50 cited
Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance
Diabetologia·2003· 110 citedOpen Access
Prevention of obesity and insulin resistance by glucokinase expression in skeletal muscle of transgenic mice
The FASEB Journal·2003· 13 cited
Overexpression of c <i>‐myc</i> in the liver prevents obesity and insulin resistance
The FASEB Journal·2003· 42 cited
Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism
Biochemical Journal·2002· 26 citedOpen Access
Glucose-Regulated Glucose Uptake by Transplanted Muscle Cells Expressing Glucokinase Counteracts Diabetic Hyperglycemia
Human Gene Therapy·2002· 9 cited
Counteraction of Type 1 Diabetic Alterations by Engineering Skeletal Muscle to Produce Insulin
Diabetes·2002· 26 citedOpen Access
Increased Fatty Acid Re-esterification by PEPCK Overexpression in Adipose Tissue Leads to Obesity Without Insulin Resistance
Diabetes·2002· 233 citedOpen Access
Expression of Glucokinase in Skeletal Muscle: A New Approach to Counteract Diabetic Hyperglycemia
Human Gene Therapy·2000· 29 cited
Insulin Production by Engineered Muscle Cells
Human Gene Therapy·1999· 34 cited
Regulated Production of Mature Insulin by Non- <i>β</i> -Cells
Human Gene Therapy·1997· 43 cited
page 1 of 2Next →

Frequent Co-authors

Fátima Bosch(18), Tura Ferré(11), Anna Pujol(9), Pedro J. Otaegui(7), Sylvie Franckhauser(6), Sergio Muñoz(4), Alfons Valera(4), Mark A. Kay(4), Alex Mas(4), Jesús Ruberte(3), Zhiying Chen(3), Laurent Gros(3), Lluı́s Montoliu(3), Ivet Elias(2), Carles Roca(2), David Ramos‐Barbón(2), Chen-Yi He(2), Hui Xu(2), Miquel García(2), Juan E. Felı́u(2)